Olin (OLN) just posted its FY 2025 results, with Q4 revenue of US$1,665.1 million and a basic EPS loss of US$1.26, compared with Q4 2024 revenue of US$1,671.3 million and basic EPS of US$0.09. Over the last six reported quarters, revenue has moved in a tight range between US$1,589.5 million and US$1,758.3 million, while quarterly basic EPS has swung from a profit of US$0.37 in Q3 2025 to losses such as the US$0.21 per share recorded in Q3 2024. For investors, that mix of steady top line and volatile EPS puts the spotlight on how management is handling margins and cost pressure from here.

See our full analysis for Olin.

With the headline numbers on the table, the next step is to see how this earnings profile lines up with the widely shared narratives about Olin’s risks, potential rewards, and path back to more stable profitability.

Trailing losses widen despite steady US$6.8b revenue base

• On a trailing 12 month view to Q4 2025, Olin generated about US$6.8b in revenue and reported a net loss of US$100.5 million, compared with a profit of US$108.6 million on roughly US$6.5b of revenue in the prior trailing period.
• Consensus narrative expects cost programs and a shift toward higher margin specialty products to improve earnings stability, yet the swing from US$108.6 million profit to a US$100.5 million loss shows that, so far, higher revenue has not translated into steadier profits.
  • Structural cost initiatives like Beyond250 are framed as supporting margins over time. However, the trailing loss suggests those benefits are not yet visible in the reported net income line.
  • Analysts looking for more resilient earnings will likely pay close attention to whether the current revenue base above US$6.7b can eventually support the forecast margin gains implied in the consensus narrative.

Q4 loss of US$143.4m tests the bullish turnaround story

• Q4 2025 flipped from a Q3 profit of US$42.8 million to a net loss of US$143.4 million, even though revenue only moved from US$1,713.2 million to US$1,665.1 million over the same period.
• Bulls argue that structural cost cuts and exposure to PVC, specialty epoxies, and ammunition can support a strong earnings recovery, yet this sharp quarterly loss highlights how sensitive current results still are to cost pressure and weaker end markets.
  • Bullish assumptions look for earnings to reach US$350.0 million and margins to rise from roughly 1.5% loss today to 4.4% profit in a few years. This contrasts with the latest quarter showing a sizeable loss on revenue that stayed in its recent range.
  • For readers weighing that bullish view, the gap between a Q4 loss of US$143.4 million and the targeted US$350.0 million profit shows how much of the upside case still sits in future execution rather than recent trailing performance.

Have a closer look at how the optimistic case lines up with these numbers by checking the 🐂 Olin Bull Case

Deep discount to DCF fair value meets weak coverage of interest and dividends

• The stock trades at US$26.76 against a DCF fair value of about US$75.79 and a P/S of 0.4x compared with 1.2x for the US Chemicals industry and 1.4x for peers, while trailing 12 month earnings of negative US$100.5 million mean interest payments and the 2.99% dividend are not well covered.
• Bears focus on that combination of unprofitable trailing results and financial coverage pressure, arguing that cyclical end markets, environmental costs, and competition could keep margins under strain even if revenue stays close to the current US$6.8b level.
  • Losses growing at about 11.1% per year over five years and modest trailing revenue growth of roughly 3% per year give critics support when they question how quickly earnings can move back to levels that comfortably fund interest and dividends.
  • At the same time, the wide gap between the DCF fair value of US$75.79 and the current US$26.76 price means any improvement in earnings coverage could have a large impact on how the stock is valued. This is exactly where bullish and bearish narratives diverge.

If you are concerned about the more cautious arguments, it is worth seeing how skeptics tie these figures together in the 🐻 Olin Bear Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Olin on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Uncertain about which side of the story feels more convincing right now? Take a moment to review the data, weigh both the concerns and potential upsides, and then check out the 3 key rewards and 2 important warning signs.

Explore Alternatives

Olin is working with a steady revenue base around US$6.8b, but recurring losses and weak coverage of interest and dividends point to meaningful financial strain.

If you want stocks where balance sheets look firmer and funding obligations appear better supported, check out the solid balance sheet and fundamentals stocks screener (44 results) today to compare potential alternatives.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.